Totals
- Total revenue
- $285,315,317
- Total expenses
- $382,452,556
- Contributions and grants received
- $165,812,985
- Grants paid
- $1,633,728
- Program service revenue
- $19,939,417
- Investment income
- $83,859,993
- Other revenue
- $15,702,922
- Total assets, end of year
- $2,184,814,083
- Total liabilities, end of year
- $984,918,509
- Net assets or fund balances, end of year
- $1,199,895,574
- Program services expenses (Part IX)
- $324,818,769
- Management and general expenses
- $57,535,835
- Fundraising expenses
- $97,952
- Program service expenses (Part III)
- $324,818,769
Program services were 84.9% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1d · Related organizations
$47,164,619
-
1e · Government grants (contributions)
$112,316,398
-
1f · All other contributions, gifts and grants
$6,331,968
-
2a · Program service revenue: Research Activities
total $18,765,463 · related or exempt $18,765,463
-
2b · Program service revenue: Specialized Lab Revenue
total $906,225 · related or exempt $906,225
-
2c · Program service revenue: Graduate Education Program
total $226,634 · related or exempt $226,634
-
2d · Program service revenue: Rental Income - Graduate Education
total $41,095 · related or exempt $41,095
-
2f · All other program service revenue
total $0 · related or exempt $0 · unrelated business $0 · excluded $0
-
3 · Investment income
total $16,232,828 · excluded $16,232,828
-
5 · Royalties
total $9,921,792 · excluded $9,921,792
-
6c · Rental income or loss
real property $0 · personal property $0
-
7a · Gross sales of assets other than inventory
securities $972,986,643
-
7b · Less cost or other basis and sales expenses
securities $905,359,478
-
7c · Gain or loss
securities $67,627,165 · other assets $0
-
7d · Net gain or loss
total $67,627,165 · excluded $67,627,165
-
11a · Other revenue: INVESTMENT INCOME - SCHEDULES K-1
total $5,781,130 · unrelated business $5,781,130
-
11d · All other revenue
total $0 · related or exempt $0 · unrelated business $0 · excluded $0
-
11e · Other revenue, total
$5,781,130
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $1,633,728 · program services $1,633,728
-
4 · Benefits paid to or for members
total $0 · program services $0
-
5 · Compensation of officers, directors and key employees
total $6,425,419 · program services $5,592,318 · management and general $830,426 · fundraising $2,675
-
7 · Other salaries and wages
total $169,475,979 · program services $147,502,217 · management and general $21,903,199 · fundraising $70,563
-
8 · Pension plan contributions
total $11,072,669 · program services $9,637,019 · management and general $1,431,040 · fundraising $4,610
-
9 · Other employee benefits
total $17,633,263 · program services $15,346,985 · management and general $2,278,936 · fundraising $7,342
-
10 · Payroll taxes
total $11,073,406 · program services $9,637,660 · management and general $1,431,135 · fundraising $4,611
-
11b · Fees: legal
total $4,825,897 · management and general $4,825,897
-
11c · Fees: accounting
total $217,974 · management and general $217,974
-
11f · Fees: investment management
total $2,240,568 · program services $1,753,837 · management and general $486,630 · fundraising $101
-
11g · Fees: other
total $22,012,938 · program services $21,180,114 · management and general $831,599 · fundraising $1,225
-
12 · Advertising and promotion
total $579,844 · program services $446,308 · management and general $133,508 · fundraising $28
-
13 · Office expenses
total $5,414,709 · program services $5,177,816 · management and general $236,827 · fundraising $66
-
14 · Information technology
total $11,238,343 · program services $8,796,799 · management and general $2,441,035 · fundraising $509
-
15 · Royalties
total $3,274,191 · program services $3,274,191
-
16 · Occupancy
total $12,465,042 · program services $9,594,420 · management and general $2,870,020 · fundraising $602
-
17 · Travel
total $2,023,113 · program services $1,557,203 · management and general $465,812 · fundraising $98
-
19 · Conferences, conventions and meetings
total $802,302 · program services $617,998 · management and general $184,265 · fundraising $39
-
20 · Interest
total $7,273,537 · program services $6,664,873 · management and general $608,664
-
22 · Depreciation, depletion and amortization
total $27,290,580 · program services $20,300,193 · management and general $6,986,961 · fundraising $3,426
-
23 · Insurance
total $273,935 · program services $210,850 · management and general $63,072 · fundraising $13
-
24a · Other expenses: Lab/Medical Supplies & Equipment
total $44,005,061 · program services $39,537,571 · management and general $4,466,462 · fundraising $1,028
-
24b · Other expenses: Repairs & Maintenance
total $6,441,052 · program services $4,972,396 · management and general $1,468,348 · fundraising $308
-
24c · Other expenses: Grants Bad Debt Expenses
total $5,367,343 · program services $4,131,278 · management and general $1,235,806 · fundraising $259
-
24d · Other expenses: Taxes, Licenses, and Business Fees
total $1,182,005 · program services $915,987 · management and general $265,962 · fundraising $56
-
24e · All other expenses
total $8,209,658 · program services $6,337,008 · management and general $1,872,257 · fundraising $393
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $60,820,327 · end of year $143,672,022
-
2 · Savings and temporary cash investments
beginning of year $17,954,726 · end of year $86,148,844
-
3 · Pledges and grants receivable
beginning of year $32,939,589 · end of year $29,548,450
-
4 · Accounts receivable
beginning of year $11,529,531 · end of year $8,599,072
-
5 · Loans and receivables from officers and key people
beginning of year $0 · end of year $0
-
6 · Loans and receivables from disqualified persons
beginning of year $0 · end of year $0
-
7 · Other notes and loans receivable
beginning of year $5,021,682 · end of year $4,811,873
-
9 · Prepaid expenses and deferred charges
beginning of year $535,171 · end of year $529,677
-
10a · Land, buildings and equipment: cost or other basis
$604,377,873
-
10b · Land, buildings and equipment: accumulated depreciation
$332,289,562
-
10c · Land, buildings and equipment, net
beginning of year $287,026,896 · end of year $272,088,311
-
11 · Investments: publicly traded securities
beginning of year $292,147,105 · end of year $384,275,005
-
12 · Investments: other securities
beginning of year $1,050,475,531 · end of year $1,151,690,625
-
13 · Investments: program-related
beginning of year $0
-
15 · Other assets
beginning of year $188,020,216 · end of year $103,450,204
-
17 · Accounts payable and accrued expenses
beginning of year $41,235,914 · end of year $43,542,459
-
19 · Deferred revenue
beginning of year $15,776,874 · end of year $26,410,374
-
20 · Tax-exempt bond liabilities
beginning of year $49,451,350 · end of year $48,761,766
-
22 · Loans and payables to officers and key people
beginning of year $0 · end of year $0
-
23 · Secured mortgages and notes payable
beginning of year $50,000,000 · end of year $50,000,000
-
25 · Other liabilities
beginning of year $672,030,774 · end of year $816,203,910
-
27 · Net assets without donor restrictions
beginning of year $1,087,515,597 · end of year $1,163,610,948
-
28 · Net assets with donor restrictions
beginning of year $30,460,265 · end of year $36,284,626
Mission and programs · 2023
Mission
THE SPECIFIC AND PRIMARY PURPOSE OF BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE IS TO DIRECTLY ENGAGE IN THE ACTIVE CONDUCT OF MEDICAL RESEARCH. PLEASE SEE SCHEDULE O FOR A CONTINUATION OF OUR MISSION.
Activities or mission (Part I)
TO DISCOVER AND TRANSLATE INNOVATIVE LABORATORY FINDINGS INTO NEW CLINICAL TREATMENTS BY USING PRACTICAL APPLICATIONS OF CHEMISTRY, PHYSICS AND BIOLOGY.
-
BIOMEDICAL RESEARCH AND DISEASE INVESTIGATIONS, INCLUDING DNA SYNTHESIS AND CELL ANALYSIS. BECKMAN RESEARCH INSTITUTE HAS PIONEERED SCIENTIFIC BREAKTHROUGHS RESULTING IN TREATMENTS THAT HAVE IMPROVED THE LIVES OF PATIENTS WORLDWIDE. NUMEROUS LIFE-SAVING DRUGS USE PATENTED TECHNOLOGY DEVELOPED AT BECKMAN RESEARCH INSTITUTE. THESE DRUGS INCLUDE SYNTHETIC HUMAN INSULIN (HUMULIN) FOR DIABETES, THE WIDELY USED CANCER DRUGS HERCEPTIN, RITUXAN AND AVASTIN, AND HUMIRA FOR ARTHRITIS. RESEARCHERS AT BECKMAN RESEARCH INSTITUTE UNDERTAKE FUNDAMENTAL INVESTIGATIONS IN DIABETES PROGRESSION AND TREATMENT, IMMUNOLOGY AND IMAGING, INTERFERING RNAS AND HIV TREATMENT, TOTAL SYNTHESIS OF COMPLEX AND THERAPEUTIC NATURAL PRODUCTS, MECHANISMS OF DRUG ACTION, NEUROGENESIS, STEM CELL THERAPY, DNA REPAIR AND RADIATION, AND THE IMMUNOBIOLOGY OF VIRAL INFECTION. THEY HAVE ACHIEVED MAJOR ADVANCES IN RECOMBINANT DNA TECHNOLOGY, MONOCLONAL ANTIBODIES, GENE THERAPY, EPIGENETICS, SI-RNA TECHNOLOGY AND CANCER IMMUNOTHERAPEUTICS. A DEPARTMENT IN BECKMAN RESEARCH INSTITUTE IS DEDICATED TO UNDERSTANDING AND DEVELOPING TREATMENTS BASED ON CANCER'S INTERACTION WITH THE IMMUNE SYSTEM. OTHER RESEARCH HAS IDENTIFIED PROTEINS THAT MAY PLAY CRITICAL ROLES IN IMMUNE RESPONSE AND MAY LEAD TO NEW TREATMENT STRATEGIES. ANOTHER MAJOR EMPHASIS FOR THE BECKMAN RESEARCH INSTITUTE SCIENTISTS IS PERSONALIZED RESEARCH AND MEDICINE -- ANALYZING A PATIENT'S UNIQUE GENETIC PROFILE TO DEVELOP TAILORED THERAPIES FOR THEIR SPECIFIC DISEASE. ALL OF THIS RESEARCH IS UNIQUELY SUPPORTED BY ONSITE MANUFACTURING FACILITIES THAT CAN TEST AND PRODUCE QUANTITIES OF CELL-BASED, GENE-BASED AND MOLECULAR THERAPIES. THESE FACILITIES FURTHER SERVE AS RESOURCES FOR MEDICAL AND SCIENTIFIC RESEARCH CENTERS NATIONWIDE. BECKMAN RESEARCH INSTITUTE SCIENTISTS SERVE AS FACULTY MEMBERS IN CITY OF HOPE'S IRELL & MANELLA GRADUATE SCHOOL OF BIOLOGICAL SCIENCES. THE GRADUATE SCHOOL'S MISSION IS TO TRAIN STUDENTS TO BE OUTSTANDING RESEARCH SCIENTISTS IN CHEMICAL, MOLECULAR AND CELLULAR BIOLOGY. THE SCHOOL IS ACCREDITED BY THE WESTERN ASSOCIATION OF SCHOOLS AND COLLEGES. GRADUATES OF THE PROGRAM, AWARDED A DOCTORATE OF PHILOSOPHY IN BIOLOGICAL SCIENCES, ARE EQUIPPED TO ADDRESS FUNDAMENTAL QUESTIONS IN LIFE SCIENCES AND BIOMEDICINE FOR CAREERS IN ACADEMIA, INDUSTRY AND GOVERNMENT.
Expenses $324,818,769 · Grants $1,633,728 · Revenue $19,939,417
As filed on the 2023 return.
Listed in Part VII
-
Steven B Fink
Director & Chair of the Board
- Total calculated
- $0
- Hours/week
- 2 + 8 related
-
Charlotte Hubbert PhD
Director
- Total calculated
- $0
- Hours/week
- 2
-
Debbie C Thurmond
Director/Professor
- Total calculated
- $457,019
- From this org
- $435,306
- From related orgs
- $0
- Other
- $21,713
- Hours/week
- 60
Schedule J breakdown matched by us
- Base
- $398,867
- Bonus
- $13,599
- Other
- $22,840
- Deferred
- $0
- Nontaxable benefits
- $21,713
- Filer's total
- $457,019
-
Emmet Stephenson
Director
- Total calculated
- $0
- Hours/week
- 2
-
Julian Husbands MD
Director
- Total calculated
- $0
- Hours/week
- 2
-
Norman Payson MD
Director
- Total calculated
- $0
- Hours/week
- 2
-
Saro Armenian DO MPH
Director/Professor
- Total calculated
- $0
- Hours/week
- 2
-
Selwyn Isakow
Director
- Total calculated
- $0
- Hours/week
- 2 + 10 related
-
Stephanie Okey
Director
- Total calculated
- $0
- Hours/week
- 2 + 4 related
-
Todd M Binder
Director
- Total calculated
- $0
- Hours/week
- 2
-
Cristin J O'Callahan
General Counsel & Corp Secretary
- Total calculated
- $1,472,464
- From this org
- $186,671
- From related orgs
- $944,668
- Other
- $341,125
- Hours/week
- 10 + 51 related
Schedule J breakdown matched by us
- Base
- $106,709 + $540,016 related
- Bonus
- $69,747 + $352,960 related
- Other
- $10,215 + $51,692 related
- Deferred
- $50,977 + $257,972 related
- Nontaxable benefits
- $5,309 + $26,867 related
- Filer's total
- $242,957 + $1,229,507 related
-
Donald J Matthewson
Assistant Treasurer
- Total calculated
- $639,380
- From this org
- $125,464
- From related orgs
- $501,856
- Other
- $12,060
- Hours/week
- 12 + 48 related
Schedule J breakdown matched by us
- Base
- $81,226 + $324,904 related
- Bonus
- $33,946 + $135,784 related
- Other
- $10,292 + $41,168 related
- Deferred
- $1,999 + $7,996 related
- Nontaxable benefits
- $413 + $1,652 related
- Filer's total
- $127,876 + $511,504 related
-
Jo Ann Escasa-Haigh
Chief Business Officer
- Total calculated
- $1,980,192
- From this org
- $365,936
- From related orgs
- $1,463,743
- Other
- $150,513
- Hours/week
- 12 + 48 related
Schedule J breakdown matched by us
- Base
- $192,096 + $768,383 related
- Bonus
- $169,340 + $677,360 related
- Other
- $4,500 + $18,000 related
- Deferred
- $24,552 + $98,207 related
- Nontaxable benefits
- $5,551 + $22,203 related
- Filer's total
- $396,039 + $1,584,153 related
-
Robert W Stone
President & CEO
- Total calculated
- $6,149,982
- From this org
- $300,338
- From related orgs
- $4,182,312
- Other
- $1,667,332
- Hours/week
- 4 + 56 related
Schedule J breakdown matched by us
- Base
- $138,742 + $1,932,032 related
- Bonus
- $147,311 + $2,051,361 related
- Other
- $14,285 + $198,919 related
- Deferred
- $109,062 + $1,518,723 related
- Nontaxable benefits
- $2,650 + $36,897 related
- Filer's total
- $412,050 + $5,737,932 related
-
Yvette Tremonti
Treasurer/Chief Financial Officer
- Total calculated
- $24,162
- From this org
- $0
- From related orgs
- $0
- Other
- $24,162
- Hours/week
- 10 + 51 related
-
Ashley Baker Lee
SVP, Research Operations
- Total calculated
- $1,222,938
- From this org
- $872,074
- From related orgs
- $218,018
- Other
- $132,846
- Hours/week
- 48 + 12 related
Schedule J breakdown matched by us
- Base
- $547,454 + $136,863 related
- Bonus
- $251,660 + $62,915 related
- Other
- $72,960 + $18,240 related
- Deferred
- $80,541 + $20,135 related
- Nontaxable benefits
- $25,736 + $6,434 related
- Filer's total
- $978,351 + $244,587 related
-
David A Horne
Vice Prvst & Depty Dir BRI & Dn Fac Aff
- Total calculated
- $1,019,212
- From this org
- $914,413
- From related orgs
- $0
- Other
- $104,799
- Hours/week
- 60
Schedule J breakdown matched by us
- Base
- $585,963
- Bonus
- $258,829
- Other
- $69,621
- Deferred
- $87,354
- Nontaxable benefits
- $17,445
- Filer's total
- $1,019,212
-
David Craig
Dep Dir, Integr Transltnl Sci
- Total calculated
- $443,476
- From this org
- $428,774
- From related orgs
- $0
- Other
- $14,702
- Hours/week
- 60
Schedule J breakdown matched by us
- Base
- $220,752
- Bonus
- $200,000
- Other
- $8,022
- Deferred
- $0
- Nontaxable benefits
- $14,702
- Filer's total
- $443,476
-
Debra F Fields
Exec VP & Chief Transformation Ofc
- Total calculated
- $2,088,520
- From this org
- $340,881
- From related orgs
- $1,363,523
- Other
- $384,116
- Hours/week
- 12 + 48 related
Schedule J breakdown matched by us
- Base
- $184,215 + $736,861 related
- Bonus
- $136,114 + $544,454 related
- Other
- $20,552 + $82,208 related
- Deferred
- $69,330 + $277,318 related
- Nontaxable benefits
- $7,494 + $29,974 related
- Filer's total
- $417,705 + $1,670,815 related
-
John D Carpten
Chf Sci Off, BRI Dir, Canc Ctr Dir
- Total calculated
- $1,139,917
- From this org
- $571,428
- From related orgs
- $467,532
- Other
- $100,957
- Hours/week
- 33 + 27 related
Schedule J breakdown matched by us
- Base
- $221,239 + $181,014 related
- Bonus
- $350,189 + $286,518 related
- Other
- $0
- Deferred
- $48,728 + $39,869 related
- Nontaxable benefits
- $6,798 + $5,562 related
- Filer's total
- $626,954 + $512,963 related
-
Marcellus R Van Den Brink MD PhD
Pres COH LA & NMC & Chf Phys Exec
- Total calculated
- $1,155,272
- From this org
- $99,787
- From related orgs
- $898,082
- Other
- $157,403
- Hours/week
- 6 + 54 related
Schedule J breakdown matched by us
- Base
- $26,144 + $242,657 related
- Bonus
- $67,000 + $596,300 related
- Other
- $6,643 + $59,125 related
- Deferred
- $15,239 + $137,147 related
- Nontaxable benefits
- $502 + $4,515 related
- Filer's total
- $115,528 + $1,039,744 related
-
Mark Hulse
Chief Digital Officer
- Total calculated
- $1,425,667
- From this org
- $276,672
- From related orgs
- $1,106,688
- Other
- $42,307
- Hours/week
- 12 + 48 related
Schedule J breakdown matched by us
- Base
- $159,761 + $639,043 related
- Bonus
- $100,658 + $402,634 related
- Other
- $16,253 + $65,011 related
- Deferred
- $5,318 + $21,274 related
- Nontaxable benefits
- $3,143 + $12,572 related
- Filer's total
- $285,133 + $1,140,534 related
-
Steven Terry Rosen MD
EVP, Dir Emeritus Comp Canc Ctr & BRI
- Total calculated
- $2,042,368
- From this org
- $1,562,947
- From related orgs
- $173,661
- Other
- $305,760
- Hours/week
- 54 + 6 related
Schedule J breakdown matched by us
- Base
- $850,948 + $94,550 related
- Bonus
- $602,590 + $66,954 related
- Other
- $109,409 + $12,157 related
- Deferred
- $260,143 + $28,905 related
- Nontaxable benefits
- $15,041 + $1,671 related
- Filer's total
- $1,838,131 + $204,237 related
-
Edward S Kim
Director, System Clin Trials
- Total calculated
- $1,722,035
- From this org
- $396,461
- From related orgs
- $1,189,384
- Other
- $136,190
- Hours/week
- 15 + 47 related
Schedule J breakdown matched by us
- Base
- $223,878 + $671,636 related
- Bonus
- $106,430 + $319,290 related
- Other
- $66,153 + $198,458 related
- Deferred
- $28,178 + $84,533 related
- Nontaxable benefits
- $5,870 + $17,609 related
- Filer's total
- $430,509 + $1,291,526 related
-
Harlan Alcon Levine
Pres, Hlth Innovation & Policy
- Total calculated
- $2,392,717
- From this org
- $364,681
- From related orgs
- $1,624,490
- Other
- $403,546
- Hours/week
- 11 + 49 related
Schedule J breakdown matched by us
- Base
- $195,927 + $872,767 related
- Bonus
- $149,177 + $664,517 related
- Other
- $19,577 + $87,206 related
- Deferred
- $66,072 + $294,321 related
- Nontaxable benefits
- $7,911 + $35,242 related
- Filer's total
- $438,664 + $1,954,053 related
-
Kristin Bertell
Chief Philanthropy Officer
- Total calculated
- $1,558,973
- From this org
- $41,469
- From related orgs
- $1,202,603
- Other
- $314,901
- Hours/week
- 2 + 58 related
Schedule J breakdown matched by us
- Base
- $21,849 + $633,610 related
- Bonus
- $17,257 + $500,460 related
- Other
- $2,363 + $68,533 related
- Deferred
- $9,214 + $267,194 related
- Nontaxable benefits
- $1,283 + $37,210 related
- Filer's total
- $51,966 + $1,507,007 related
-
Larry Kwak
Deputy Dir, Comp Cancer Ctr
- Total calculated
- $1,092,000
- From this org
- $1,040,975
- From related orgs
- $0
- Other
- $51,025
- Hours/week
- 60
Schedule J breakdown matched by us
- Base
- $767,345
- Bonus
- $185,418
- Other
- $88,212
- Deferred
- $26,592
- Nontaxable benefits
- $24,433
- Filer's total
- $1,092,000
-
Vijay Trisal MD
System Chief Clinical Officer
- Total calculated
- $1,259,854
- From this org
- $37,057
- From related orgs
- $1,074,649
- Other
- $148,148
- Hours/week
- 2 + 58 related
Schedule J breakdown matched by us
- Base
- $24,176 + $701,101 related
- Bonus
- $10,201 + $295,833 related
- Other
- $2,680 + $77,715 related
- Deferred
- $3,751 + $108,780 related
- Nontaxable benefits
- $1,187 + $34,430 related
- Filer's total
- $41,995 + $1,217,859 related
-
Jennifer Parkhurst
Former Officer
- Total calculated
- $1,629,131
- From this org
- $312,857
- From related orgs
- $1,251,429
- Other
- $64,845
- Hours/week
- 12 + 48 related
Schedule J breakdown matched by us
- Base
- $136,392 + $545,569 related
- Bonus
- $80,007 + $320,027 related
- Other
- $96,458 + $385,833 related
- Deferred
- $5,018 + $20,073 related
- Nontaxable benefits
- $7,951 + $31,803 related
- Filer's total
- $325,826 + $1,303,305 related
-
Philip Okala
FORMER OFFICER
- Total calculated
- $892,045
- From this org
- $175,540
- From related orgs
- $702,160
- Other
- $14,345
- Hours/week
- 12 + 48 related
Schedule J breakdown matched by us
- Base
- $137,410 + $549,640 related
- Bonus
- $0
- Other
- $38,130 + $152,520 related
- Deferred
- $0
- Nontaxable benefits
- $2,869 + $11,476 related
- Filer's total
- $178,409 + $713,636 related
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 1a · First-class or charter travel
- 1b · Written policy on the line-1a expenses
- 2 · Substantiation required before reimbursing expenses
- 3 · Compensation committee
- 3 · Independent compensation consultant
- 3 · Form 990 of other organizations
- 3 · Written employment contract
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
- 4b · Supplemental nonqualified retirement plan
- 7 · Other non-fixed payments
Answered no
- 4a · Severance or change-of-control payment
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- Schedule J, Part I, Line 1a First-class or charter travel
- BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE PERMITS FIRST CLASS TRAVEL FOR CERTAIN OFFICERS, DIRECTORS, AND KEY EXECUTIVES IN LIMITED CIRCUMSTANCES WHEN SPECIFIED TRAVEL CRITERIA ARE MET.
- Schedule J, Part I, Line 4b Supplemental nonqualified retirement plan
- CITY OF HOPE HAS A NON QUALIFIED SECTION 457(F) EXECUTIVE SUPPLEMENTAL ACCUMULATION PLAN THAT IS DESIGNED AND MAINTAINED TO PROVIDE A SELECT GROUP OF MANAGEMENT OR HIGHLY COMPENSATED EMPLOYEES WITH DEFERRED COMPENSATION. THE PLAN VESTS AFTER THREE (3) FISCAL YEARS OF SERVICE AND THE VESTED TOTALS ARE INCLUDED IN SCHEDULE J, PART II, COLUMN (B) (III). PRIOR TO VESTING, THE ANNUAL CONTRIBUTION AMOUNTS ARE INCLUDED IN SCHEDULE J, PART II, COLUMN (C). PURSUANT TO THE PLAN DOCUMENT, VESTED PARTICIPANTS ARE ENTITLED TO WITHDRAW FROM THEIR VESTED ACCOUNT AN AMOUNT EQUAL TO THE FEDERAL, STATE, LOCAL AND FICA TAXES THEY OWE. THESE AMOUNTS ARE REMITTED TO THE APPROPRIATE TAXING AUTHORITIES ON BEHALF OF THE PARTICIPANTS. FOR CALENDAR YEAR 2023, THE FOLLOWING INDIVIDUALS WITHDREW THE REFERENCED AMOUNTS TO COVER SUCH TAXES: ASHLEY BAKER LEE - $19,924 DEBRA FIELDS - $35,501 DAVID HORNE - $17,616 MARK HULSE - $28,478 EDWARD KIM - $84,759 DONALD MATTHEWSON - $10,014 STEVEN TERRY ROSEN - $34,090 ROBERT STONE - $59,965 VIJAY TRISAL - $17,540
- Schedule J, Part I, Line 7 Non-fixed payments
- BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE'S EXECUTIVES AND CERTAIN KEY EMPLOYEES ARE ELIGIBLE TO RECEIVE INCENTIVE COMPENSATION UNDER AN ANNUAL INCENTIVE PLAN (AIP) TIED TO ORGANIZATIONAL KEY PERFORMANCE INDICATORS AND INDIVIDUAL OBJECTIVES. THE KEY PERFORMANCE INDICATORS REFLECT KEY AREAS OF STRATEGIC FOCUS AND THE EXEMPT HEALTHCARE MISSION OF CITY OF HOPE AND AFFILIATES AND ARE BOTH FINANCIAL AND NON-FINANCIAL. THE POTENTIAL INCENTIVE COMPENSATION IS BASED ON A WEIGHTED AVERAGE AMONG ALL INDICATORS AND IS PAID AS A PERCENTAGE OF EACH INDIVIDUAL PARTICIPANT'S BASE COMPENSATION. THE KEY PERFORMANCE INDICATORS ARE WEIGHTED BASED ON THE PARTICIPANT'S PRIMARY AREA(S) OF RESPONSIBILITY, WITH ORGANIZATIONAL KEY PERFORMANCE INDICATORS WEIGHTED FROM 70 PERCENT TO 90 PERCENT, AND THE INDIVIDUAL OBJECTIVES WEIGHTED FROM 10 PERCENT TO 30 PERCENT. THE AIP IS UNDER THE CONTROL OF, AND ADMINISTERED BY, THE INDEPENDENT DIRECTORS SERVING ON THE EXECUTIVE COMPENSATION AND GOVERNANCE COMMITTEE. TO BE ELIGIBLE, THE PARTICIPANTS IN THE AIP MUST BE EMPLOYED BY CITY OF HOPE AT THE TIME OF THE INCENTIVE PLAN PAYMENT, AND BE MEETING OR EXCEEDING PERFORMANCE EXPECTATIONS. CITY OF HOPE MAY, IN ITS DISCRETION, CANCEL ALL OR A PORTION OF ANY INCENTIVE PLAN PAYMENT OR AWARD TO ANY PARTICIPANT, WHETHER BEFORE OR FOLLOWING PAYMENT OF SUCH AWARD, SUBJECT TO COMPLIANCE WITH APPLICABLE LAW, UNDER THE FOLLOWING CIRCUMSTANCES (CANCELLATION POLICY): A) AN INCENTIVE PLAN PAYMENT OR AWARD IS MADE FOR A FISCAL PERIOD AND CITY OF HOPE SUBSEQUENTLY RESTATES OR OTHERWISE ADJUSTS THE ANNUAL PERFORMANCE MEASUREMENT CALCULATION IN A MANNER THAT WOULD REDUCE THE SIZE OF THE AWARD OR PAYMENT, OR; B) AN INCENTIVE PLAN PAYMENT OR AWARD IS MADE FOR A FISCAL PERIOD AND CITY OF HOPE SUBSEQUENTLY DETERMINES THAT ONE OF MORE OF THE ANNUAL PERFORMANCE MEASUREMENT CALCULATIONS ON WHICH THE AWARD IS BASED OR IS PAID ARE MATERIALLY INACCURATE. THE AIP INCENTIVE COMPENSATION EARNED FOR FISCAL YEAR 2023 WAS PAID IN CALENDAR YEAR 2023 AND THESE AMOUNTS HAVE BEEN REPORTED IN SCHEDULE J, PART II, COLUMN (B)(II). ADDITIONALLY, BECKMAN RESEARCH INSTITUTE HAS AN EXECUTIVE LONG-TERM INCENTIVE (LTI) PLAN FOR CERTAIN EXECUTIVES WHICH IS DESIGNED TO DRIVE LONG-TERM ORGANIZATIONAL PERFORMANCE AND TRANSFORMATION BY ALIGNING EXECUTIVES WITH THE MULTI-YEAR STRATEGIC PLAN AND INCENTIVIZING THEM FOR ACHIEVING KEY ORGANIZATIONAL AND STRATEGIC OBJECTIVES AND GOALS. WITH THREE-YEAR VESTING PERIODS, THE PLAN ALSO PROVIDES A MEANS FOR RETAINING KEY EXECUTIVE TALENT. THE PERFORMANCE PERIOD OF THE PLAN (CYCLE 9) RAN FROM OCTOBER 1, 2020 THROUGH SEPTEMBER 30, 2023 WITH A NEW THREE-YEAR PERFORMANCE PERIOD BEGINNING EACH OCTOBER 1ST THEREAFTER (E.G., CYCLE 10 RUNS FROM OCTOBER 1, 2021 THROUGH SEPTEMBER 30, 2024). TO BE ELIGIBLE TO PARTICIPATE IN ANY PAYOUT UNDER THE PLAN, PARTICIPANTS MUST BE ACTIVELY EMPLOYED BY BECKMAN RESEARCH INSTITUTE AT THE TIME OF THE INCENTIVE PLAN PAYMENT, AND BE MEETING OR EXCEEDING PERFORMANCE EXPECTATIONS. WHILE THE PLAN DOES MEET THE REQUIREMENTS FOR A SUBSTANTIAL RISK OF FORFEITURE, AS OF THE CALENDAR YEAR ENDING DECEMBER 31, 2023, THE POTENTIAL LTI AMOUNTS HAVE BEEN ESTIMATED AND ACCRUED DURING THE CURRENT TAX YEAR AND ARE REPORTED AS DEFERRED COMPENSATION TO THE PLAN PARTICIPANTS IN SCHEDULE J, PART II, COLUMN (C). THE LTI PLAN IS SUBJECT TO THE SAME CANCELLATION POLICY AS THE AIP DESCRIBED PREVIOUSLY. PARTICIPANTS WHO MET THE ELIGIBILITY CRITERIA RECEIVED A PAYOUT OF PLAN CYCLE 9 LTI INCENTIVES (OCTOBER 1, 2020 THROUGH SEPTEMBER 30, 2023) IN DECEMBER 2023. THESE AMOUNTS HAVE BEEN REFLECTED IN SCHEDULE J, PART II, COLUMN (B)(II).
- Schedule J, Part II Employees serving as members of the board of directors
- DEBBIE THURMOND, PH.D., IS MEMBER OF THE BECKMAN RESEARCH INSTITUTE'S BOARD OF DIRECTORS IN ADDITION TO BEING AN EMPLOYEE OF BECKMAN RESEARCH INSTITUTE. DR. THURMOND IS THE DIRECTOR OF THE ARTHUR RIGGS DIABETES & METABOLISM RESEARCH INSTITUTE AND A RENOWNED RESEARCH SCIENTIST, PROFESSOR AND THE FOUNDING CHAIR OF THE DEPARTMENT OF MOLECULAR AND CELLULAR ENDOCRINOLOGY. NONE OF THESE INDIVIDUALS WERE COMPENSATED FOR THEIR SERVICES AS MEMBERS OF THE BECKMAN RESEARCH INSTITUTE'S BOARD OF DIRECTORS. COMPENSATION EARNED BY THOSE INDIVIDUALS EMPLOYED BY BECKMAN RESEARCH INSTITUTE IS REPORTED ON FORM 990, PART VII, SECTION A AND SUBSEQUENTLY ON SCHEDULE J, PART II.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
OPERATING SUPPORT
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
501(c)(3) · Fundraising · CA
Directly controlled by NA
-
City of Hope Medical Foundation
501(c)(3) · Healthcare · CA · controlled entity
Directly controlled by City of Hope
-
City of Hope National Medical Center
501(c)(3) · Hospital · CA · controlled entity
Directly controlled by City of Hope
-
501(c)(3) · Support · DE · controlled entity
Directly controlled by City of Hope
-
Midwestern Regional Medical Center Inc
501(c)(3) · Hospital · IL · controlled entity
Directly controlled by COH HOLDCO INC
-
Southeastern Regional Medical Center Inc
501(c)(3) · Hospital · GA · controlled entity
Directly controlled by COH HOLDCO INC
-
The Translational Genomics Research Institute
501(c)(3) · Research · AZ · controlled entity
Directly controlled by City of Hope
-
The Translational Genomics Research Institute Foundation
501(c)(3) · Fundraising · AZ · controlled entity
Directly controlled by TGEN
-
Western Regional Medical Center Inc
501(c)(3) · Hospital · AZ · controlled entity
Directly controlled by COH HOLDCO INC
Taxable family on this return
Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.
Related partnerships
Part III: related organizations taxable as a partnership, with the filer's share.
-
AccessHope LLC
N/A · Oncology Support · DE
Directly controlled by NA
-
Southern California Radiation Oncology LLC
N/A · Radiation Oncology · DE
Directly controlled by NA
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 13 August 2025
- IRS schema version
- 2023v6.0
- Source object
- 202512259349301831
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.